Reports of HIV and COVID-19 coinfection: case reports, retrospective cohorts and outcomes

No benefit from hydroxychloroquine, with or without macrolide antibiotics in analysis of 96,000 patients

Remdesivir improves recovery time in early COVID-19 infection: first definitive results of benefit

Cabotegravir long-acting injections prevent HIV as PrEP

Featured HIV and COVID-19: issue 3 (14 May 2020)

Higher rates of serious outcomes in HIV and COVID-19 coinfection in Germany: cautious review

HIV is not linked to higher risk of COVID-19 in large New York cohort

Case-studies show darunavir does not protect against CoV-2

COVID-19 could lead to 500,000 excess HIV-related deaths in sub-Saharan Africa linked to interruptions in ART supply

Remdesivir for COVID-19: randomised study shows similar antiviral effect to placebo

Other remdesivir news: top results from NIH and Gilead studies – emergency approval in US and Japan

Potential for tocilizumab to treat moderate to severe COVID-19

Detectable viral load and IL-6: a role for tocilizumab or anti-JAK inhibitor baricitinib?

Rheumatoid arthritis drug anakinra in small study to treat COVID-19

Anticoagulants associated with improved survival rates in people hospitalised with COVID-19

Monoclonal antibodies identified in convalescent plasma COVID-19

Studies reporting lack of benefit from hydroxychloroquine to treat COVID-19

Israeli cohort shows no protection against COVID-19 from childhood BCG vaccination

Obesity associated with worse outcomes in younger people hospitalised with COVID-19 in the US

ACE inhibitors and angiotensin receptor blockers do not boost risk of COVID-19 or flu

ACE inhibitors and angiotensin receptor blockers for hypertension tied to lower death risk with COVID-19

New BHIVA guidelines: B/F/TAF now preferred first-line ART and reduced HIV monitoring in the UK during COVID-19

Joint BHIVA/EACS update on HIV and COVID-19 (April 2020)

Interim US guidance for coinfection COVID-19 and HIV

Potential for CoV-2 to be widely distributed in cells throughout the body

Reports of Kawasaki-like disease in children after the start of the SARS-CoV-2 epidemic in Italy 

Debate over development of pathogenic strains of CoV-2

Coronavirus: the risks – know them – avoid them

Articles supporting wider use of face masks

US groups protest political cuts to COVID-19 research

Guide to homecare and COVID-19

Reviews on immunology of COVID-19

Future meetings 2020/21

HIV and COVID-19 bulletin no 3 (14 May 2020)

Featured HTB 17 April 2020: CROI 2020 and COVID-19 supplement

i-Base appeal 2020 – we need your help

U=U resources for UK clinics: free posters, postcards and factsheets

Conference on Retroviruses and Opportunistic Infections (CROI 2020)

Predicted diabetes risk with first-line ART regimens: results from the ADVANCE trial

Dolutegravir-based ART is safe and effective for pregnant women: first results from the VESTED trial

A step forward for AAV-mediated delivery of bNAbs

10th International Workshop of HIV & Women

No neural tube defects among pregnancies with periconception dolutegravir exposure in the Dolomite-EPPICC cohort study

PrEP recommended by NHS England (at last)

Why it is important to include HIV status and HIV testing in managing COVID-19

COVID-19 symptoms in HIV positive people similar to general population in Wuhan 

Case study of COVID-19 in HIV positive person with history of HCV

Case series of five HIV positive people diagnosed with COVID-19 in Spain

Evidence review for treatment: IDSA guidelines for COVID-19

Remdesivir for COVID-19: first results from compassionate access programme

No benefit of hydroxychloroquine and azithromycin in people hospitalised with COVID-19

High-dose chloroquine study for COVID-19 stopped with worse outcomes: high risk of cardiovascular events

Potential treatments for COVID-19 could be manufactured for $1 a day or less

MSF calls for no patents or profiteering on COVID-19 drugs, tests, and vaccines in pandemic

Gilead expand UK sites for two phase-3 studies of remdesivir to treat COVID-19

Community survey on impact of COVID-19 and chemsex

Prospective cohorts to study COVID-19 including HIV

COVID-19 prophylaxis using TDF/FTC and low-dose hydroxychloroquine in Spanish health workers

European rapid community assessment reports for COVID-19

A clinical-therapeutic staging proposal for COVID-19

Four papers on CoV-2 transmission

Studies stoke concern about coronavirus contagion through air via speech

BASHH responses to impact of COVID-19 on sexual health services

FDA reduces restrictions on gay men donating blood in the US due to COVID-19

CoV-2 identified in blood donations in China

Post navigation